News18 » Videos » News18 Shorts

Covaxin Begins Phase I Of Human Trials While Oxford-AstraZeneca Vaccine To Undergo Phase III Trials

Jul 28, 2020 12:57 PM IST India India
Share

Five sites across India are ready for the third & final phase of human trials of the Oxford-AstraZeneca COVID-19 vaccine. The trials results for the first two phases were published earlier this month. On July 20, scientists announced that the Oxford University vaccine appears to be safe & induces strong immune response after Phase I of the human trials.

Loading